Altered expression of annexin II in human B-cell lymphoma cell lines.
Annexin II is a growth-regulated gene, whose expression is significantly increased in various human cancers. We examined annexin II expression in II human B-cell lymphoma cell lines and in normal B-cells. Wide variation was observed in the levels of annexin II in these cell lines. Annexin II overexpression was observed in 5 cell lines, while significantly reduced expression was observed in Raji, OMA-BL-1 and REH cell lines. Analysis of the annexin II gene, mRNA and protein in Raji and OMA-BL-1 cell lines indicated that annexin II gene was unaltered and that a low level of annexin II transcripts are produced in these cells. Down-regulation of annexin II expression was at the transcriptional level, and no reexpression of annexin II was observed after treatment of cells with demethylating agents. Thus methylation of the annexin II gene does not appear to be responsible for annexin II down-regulation. A slow migrating altered form of annexin II was detected in Raji and OMA-BL-1 cells, which was detected with the anti-chicken annexin II antiserum, but not with the anti-human annexin II antiserum. The slow migrating annexin II species was found to be sensitive to dephosphorylation by calf intestinal alkaline phosphatase, resulting in reduction of the size of the protein on SDS-polyacrylamide gels. The phosphorylated annexin II was also observed in nuclear extracts of human K562 and HeLa cells. Thus, Raji and OMA-BL-1 cells exclusively produce a phosphorylated form of annexin II, and phosphorylated annexin II may be important for cell survival and proliferation.
Chiang
Y
Y
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha 68198-4525, USA.
Davis
R G
RG
Vishwanatha
J K
JK
D000469:Alkaline Phosphatase; D017306:Annexin A2 / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D001402:B-Lymphocytes / Q000737:chemistry*; D002467:Cell Nucleus / Q000737:chemistry; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D007106:Immune Sera; D004915:Leukemia, Erythroblastic, Acute; D016393:Lymphoma, B-Cell / Q000737:chemistry*; D010766:Phosphorylation; D012333:RNA, Messenger / Q000032:analysis; D014407:Tumor Cells, Cultured
D017306:Annexin A2; D004791:Enzyme Inhibitors; D007106:Immune Sera; D012333:RNA, Messenger; D000077209:Decitabine; D015254:DNA Modification Methylases; D000469:Alkaline Phosphatase; D001374:Azacitidine